Ref.: VT 47 850
PROTEQFLU 10X1DS
Influenza
Si vous êtés déjà inscrit, connectez-vous à GirovetPro
Description
PHARMACEUTICAL FORM
Injectable suspension.
SPECIES
Horses.
Injectable suspension.
SPECIES
Horses.
Indications
Active immunization of horses 4 months of age or older against equine influenza for the reduction of clinical signs and viral excretion after infection.
- Start of immunity: 14 days after the primary vaccination.
- Duration of immunity induced by the vaccine schedule: 5 months after the primary vaccination and 1 year after the third vaccination.
- Start of immunity: 14 days after the primary vaccination.
- Duration of immunity induced by the vaccine schedule: 5 months after the primary vaccination and 1 year after the third vaccination.
Dose / Application / Administration
Route of administration:
Intramuscular.
Dosage:
- First vaccine schedule - Vaccination against equine influenza:
Administer one dose (1ml of ProteqFlu), by intramuscular injection, preferably in the neck, according to the following vaccination schedule:
Intramuscular.
Dosage:
- First vaccine schedule - Vaccination against equine influenza:
Administer one dose (1ml of ProteqFlu), by intramuscular injection, preferably in the neck, according to the following vaccination schedule:
- Primary vaccination: first injection from 5 – 6 months, second injection 4 – 6 weeks later.
- Booster injection: 5 months after the primary vaccination, and then annual boosters.
- Second vaccine schedule - Vaccination against equine influenza and tetanus:
Administer one dose (1ml) by intramuscular injection, preferably in the neck, according to the following vaccination schedule:
Administer one dose (1ml) by intramuscular injection, preferably in the neck, according to the following vaccination schedule:
- Primary vaccination with ProteqFlu-Te: first injection from 5 – 6 months, second injection 4 – 6 weeks later.
- Booster injection: 5 months after the primary vaccination with ProteqFlu-Te. Followed by: or against tetanus: injection of 1 dose with a maximum interval of 2 years with ProteqFlu-Te. / Or against equine influenza: injection of 1 dose every year, alternatively with ProteqFlu or ProteqFlu-Te, respecting a maximum interval of 2 years for the tetanus component.
It can be used during pregnancy and lactation.
Composition
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each dose of 1ml contains:
Active substance:
Recombinant canaripox virus Influenza A/eq/Ohio/03 [H3N8] (vCP2242): ≥ 5,3 log10 DIIF50*
Recombinant canaripox virus Influenza A/eq/Richmond/1/07 [H3N8] (vCP3011): ≥ 5,3 log10 DIIF50*
*vCP content checked by DIIF50 global (infectious dose 50 % by immunofluorescence) and qPCR ratio between vCP.
Adjuvant:
Carbomer: 4mg
Each dose of 1ml contains:
Active substance:
Recombinant canaripox virus Influenza A/eq/Ohio/03 [H3N8] (vCP2242): ≥ 5,3 log10 DIIF50*
Recombinant canaripox virus Influenza A/eq/Richmond/1/07 [H3N8] (vCP3011): ≥ 5,3 log10 DIIF50*
*vCP content checked by DIIF50 global (infectious dose 50 % by immunofluorescence) and qPCR ratio between vCP.
Adjuvant:
Carbomer: 4mg
Presentation
10 vials of 1ml
Laboratory
BOEHRINGER
Laissez-nous votre commentaire